Only one certainty here.It's a waiting game. Waiting for news, waiting for a deal, waiting for the FDA. And management always puts the blame someewhere else. So far every milestone, over the last 20 years, has not been met. There is always another hurtle, more great promises, more delays.
I like edrose's suggestion that we should demand the FA correspondence be disclosed as it is "material", ie essential information that should be available to anyone considering an iinvestment in PLI. It has been disclosed to potential partners, enders, and buyers, why not to shareholders?